Research and Markets: Global Metastatic Adenocarcinoma of The Pancreas Therapeutics Pipeline Review, H2 2015
November 27 2015 - 8:32PM
Business Wire
Research and Markets
(http://www.researchandmarkets.com/research/vrf2bt/metastatic) has
announced the addition of the "Metastatic Adenocarcinoma of The
Pancreas - Pipeline Review, H2 2015" report to their offering.
This report provides comprehensive information on the
therapeutic development for Metastatic Adenocarcinoma of The
Pancreas, complete with comparative analysis at various stages,
therapeutics assessment by drug target, mechanism of action (MoA),
route of administration (RoA) and molecule type, along with latest
updates, and featured news and press releases. It also reviews key
players involved in the therapeutic development for Metastatic
Adenocarcinoma of The Pancreas and special features on late-stage
and discontinued projects.
The report enhances decision-making capabilities and help to
create effective counter strategies to gain competitive advantage.
It strengthens R&D pipelines by identifying new targets and
MoAs to produce first-in-class and best-in-class products.
Companies Involved in Therapeutics Development
- Aduro BioTech, Inc.
- Array BioPharma Inc.
- Axcentua Pharmaceuticals AB
- Biothera, Inc.
- Boehringer Ingelheim GmbH
- Boston Biomedical, Inc.
- CTI BioPharma Corp.
- CytRx Corporation
- Eleison Pharmaceuticals, Inc.
- Gilead Sciences, Inc.
- Halozyme Therapeutics, Inc.
- Incyte Corporation
- MedImmune, LLC
- Merrimack Pharmaceuticals, Inc.
- Millennium Pharmaceuticals, Inc.
- Nanotherapeutics, Inc.
- NewLink Genetics Corporation
- Novartis AG
- Pfizer Inc.
- Phoenix Biotechnology, Inc.
- Sanofi
- Targovax AS
- Teva Pharmaceutical Industries Limited
- Threshold Pharmaceuticals, Inc.
For more information visit
http://www.researchandmarkets.com/research/vrf2bt/metastatic
View source
version on businesswire.com: http://www.businesswire.com/news/home/20151127005408/en/
Research and MarketsLaura Wood, Senior
Managerpress@researchandmarkets.comFor E.S.T Office Hours Call
1-917-300-0470For U.S./CAN Toll Free Call 1-800-526-8630For GMT
Office Hours Call +353-1-416-8900U.S. Fax: 646-607-1907Fax (outside
U.S.): +353-1-481-1716Sector: Oncology